Joel Barker

Interviews with Joel Barker RSS Feed

Joel Barker joins Jim Blasingame to report on several futuristic innovations that are now, or soon will be, our reality, including graphene applications, 3D printing expansion, and electric vehicle growth.
Joel Barker joins Jim Blasingame to report on innovations that are about to become our reality, including small atomic reactors to create municipal electricity and medical innovations, including vaccine and stem cell progress.
Joel Barker joins Jim Blasingame to report on some of the many internal challenges China has which creates the potential for that country to be a bigger threat to itself than to its competitor/enemies.
Joel Barker joins Jim Blasingame to report on a new breakthrough in medicine about a treatment that pierces the outer coating of Gam-negative bacteria and kills these deadly previously antibiotic resistant vectors.
Joel Barker joins Jim Blasingame to report on the significant investment Bill Gates is making in a new kind of nuclear power, specifically in the kind of sodium solution that would absorb the heat from the nuclear core.
Joel Barker joins Jim Blasingame to report on a new process that would make graphene from old tires and blend that into the production of concrete to make it much stronger.
Paradigm shift: New drug may reverse cognitive decline
Joel Barker joins Jim Blasingame to reveal new understanding of cognitive decline, and a new drug that addresses that new paradigm for mental recovery.
New paradigm: converting wind to electric to hydrogen
Joel Barker joins Jim Blasingame to report on a new process that converts wind power into electricity, which is used to produce hydrogen energy, thus addressing the sustainability, transportation and storage of energy.
Paradigm shift: your next biometric joint may be from a 3-D printer
Joel Barker joins Jim Blasingame to report on how 3D printing is being used in a new method that creates an improved bone joint faster, cheaper and stronger.
Joel Barker joins Jim Blasingame to reveal new understanding of cognitive decline, and a new drug that addresses that new paradigm for mental recovery.